NO20021732L - N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler - Google Patents

N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler

Info

Publication number
NO20021732L
NO20021732L NO20021732A NO20021732A NO20021732L NO 20021732 L NO20021732 L NO 20021732L NO 20021732 A NO20021732 A NO 20021732A NO 20021732 A NO20021732 A NO 20021732A NO 20021732 L NO20021732 L NO 20021732L
Authority
NO
Norway
Prior art keywords
pro
methods
protein kinase
inflammatory agents
receptor complex
Prior art date
Application number
NO20021732A
Other languages
English (en)
Other versions
NO20021732D0 (no
Inventor
James A Clagett
Craig Palmer
Original Assignee
Histatek Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Histatek Llc filed Critical Histatek Llc
Publication of NO20021732D0 publication Critical patent/NO20021732D0/no
Publication of NO20021732L publication Critical patent/NO20021732L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO20021732A 1999-10-15 2002-04-12 N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler NO20021732L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15967799P 1999-10-15 1999-10-15
PCT/US2000/028183 WO2001029069A1 (en) 1999-10-15 2000-10-12 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent

Publications (2)

Publication Number Publication Date
NO20021732D0 NO20021732D0 (no) 2002-04-12
NO20021732L true NO20021732L (no) 2002-06-12

Family

ID=22573520

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021732A NO20021732L (no) 1999-10-15 2002-04-12 N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler

Country Status (16)

Country Link
EP (1) EP1222199A4 (no)
JP (1) JP2004507441A (no)
KR (1) KR20020057972A (no)
CN (1) CN100497374C (no)
AU (1) AU8014200A (no)
BR (1) BR0014742A (no)
CA (1) CA2387559A1 (no)
CZ (1) CZ20021342A3 (no)
EA (1) EA200200451A1 (no)
HU (1) HUP0203688A2 (no)
IL (1) IL149125A0 (no)
MX (1) MXPA02003782A (no)
NO (1) NO20021732L (no)
PL (1) PL356096A1 (no)
WO (1) WO2001029069A1 (no)
ZA (1) ZA200202937B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20070116687A1 (en) * 2003-05-13 2007-05-24 Medvet Science Pty, Ltd. Method of modulating cellular transmigration and agents for use therein
WO2007004869A2 (en) 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
WO2011036308A1 (en) * 2009-09-28 2011-03-31 Theramab Gmbh Method for preclinical testing of immunomodulatory drugs
CN115466306B (zh) * 2022-01-25 2025-06-27 香港中文大学（深圳） 一种靶向细胞膜表面甲酰肽受体的多肽、药物组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025372A1 (en) * 1997-11-13 1999-05-27 Histatek, Llc Small peptides and methods for treatment of asthma and inflammation

Also Published As

Publication number Publication date
PL356096A1 (en) 2004-06-14
KR20020057972A (ko) 2002-07-12
MXPA02003782A (es) 2002-12-13
EA200200451A1 (ru) 2002-10-31
EP1222199A1 (en) 2002-07-17
WO2001029069A1 (en) 2001-04-26
EP1222199A4 (en) 2003-03-12
CA2387559A1 (en) 2001-04-26
JP2004507441A (ja) 2004-03-11
CN100497374C (zh) 2009-06-10
HUP0203688A2 (hu) 2003-02-28
CN1633447A (zh) 2005-06-29
ZA200202937B (en) 2003-09-23
NO20021732D0 (no) 2002-04-12
BR0014742A (pt) 2002-08-27
CZ20021342A3 (cs) 2003-01-15
IL149125A0 (en) 2002-11-10
AU8014200A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DK1035115T3 (da) 4-phenylpyridinderivater og anvendelse deraf som NK-1-receptorantagonister
DK0808312T3 (da) Indolderivater som 5-HT-receptorantagonist
NO981477L (no) Pyrimidinderivater som 5HT2C-reseptor antagonister
CY2010003I1 (el) Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων
DE69831176D1 (de) Kappa rezeptor opioid peptide
NO2006004I1 (no) Erlotinib hydroklorid og farmasoytisk akseptable salter derav
DE69232072D1 (de) Endothelin-rezeptor-antagonisten
NO964955D0 (no) Toveis plugganordning for bruk i en borebrönn
DK1224175T3 (da) Benzodiazepinderivater som metabotropiske glutamatreceptorantagonister
AU5274499A (en) Therapeutic chemokine receptor antagonists
FI960953A7 (fi) Endoteliinireseptoriantagonisteja
NO2005007I1 (no) Pemetrexed og farmasoytisk akseptable salter derav
DK0741133T3 (da) Adhæsionsreceptorantagonister
DE50005934D1 (de) Punktual-stimulations-therapiegerät
NO20021732D0 (no) N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel
NO995482D0 (no) Ergolinderivater og deres anvendelse som somatostatinreseptorantagonister
IL148515A0 (en) Human g-protein coupled receptor
NO963331D0 (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
IL196053A0 (en) Novel human g-protein coupled receptor
ATE341324T1 (de) Endothelin rezeptor antagonisten
GB2363793B (en) Molecular cloning of a 7TM receptor (AXOR34) and screening methods thereof
DK1237539T3 (da) Oral oplösning indeholdende galanthamin og et södemiddel
ATE326971T1 (de) Pharmazeutische suspension mit nevirapine hemihydrat
EP0812196A4 (en) ALPHA 1A ADRENERGIC RECEPTOR ANTAGONISTS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application